Cerus Corp (CERS) stock
CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3027% below fair value
$1.94−0.18 (-8.49%)
Close on Nov 12, 2026Market cap $390.96MP/E –Yield –
Cerus total assets
Total assets on the balance sheet at the end of each period.
Cerus's total assets was $204.73M at Sep 30, 2026. For fiscal 2025 it was $221.86M, up 10.4% from the year before. Over ten years it grew 4.8% a year on average. The highest annual figure on record is $237.50M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $221.86M | +10.4% |
| FY2024 | Dec 31, 2024 | $200.92M | +1.6% |
| FY2023 | Dec 31, 2023 | $197.75M | -9.3% |
| FY2022 | Dec 31, 2022 | $218.09M | -8.2% |
| FY2021 | Dec 31, 2021 | $237.50M | +7.3% |
| FY2020 | Dec 31, 2020 | $221.42M | +33.8% |
| FY2019 | Dec 31, 2019 | $165.54M | +1.3% |
| FY2018 | Dec 31, 2018 | $163.46M | +66.4% |
| FY2017 | Dec 31, 2017 | $98.24M | -5.1% |
| FY2016 | Dec 31, 2016 | $103.48M | -25.8% |
| FY2015 | Dec 31, 2015 | $139.40M | +70.5% |
| FY2014 | Dec 31, 2014 | $81.78M | -1.9% |
| FY2013 | Dec 31, 2013 | $83.38M | +70.4% |
| FY2012 | Dec 31, 2012 | $48.92M | +7.8% |
| FY2011 | Dec 31, 2011 | $45.37M | -5.8% |
| FY2010 | Dec 31, 2010 | $48.17M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $204.73M | -4.9% |
| Q2 FY2026 | Jun 30, 2026 | $205.19M | -3.7% |
| Q1 FY2026 | Mar 31, 2026 | $222.91M | +7.8% |
| Q4 FY2025 | Dec 31, 2025 | $221.86M | +10.4% |
| Q3 FY2025 | Sep 30, 2025 | $215.19M | +13.5% |
| Q2 FY2025 | Jun 30, 2025 | $213.07M | +14.9% |
| Q1 FY2025 | Mar 31, 2025 | $206.78M | +9.3% |
| Q4 FY2024 | Dec 31, 2024 | $200.92M | +1.6% |
| Q3 FY2024 | Sep 30, 2024 | $189.54M | -7.9% |
| Q2 FY2024 | Jun 30, 2024 | $185.50M | -6.7% |
| Q1 FY2024 | Mar 31, 2024 | $189.14M | -9.6% |
| Q4 FY2023 | Dec 31, 2023 | $197.75M | -9.3% |
| Q3 FY2023 | Sep 30, 2023 | $205.84M | -4.4% |
| Q2 FY2023 | Jun 30, 2023 | $198.86M | -8.1% |
| Q1 FY2023 | Mar 31, 2023 | $209.34M | -5.7% |
| Q4 FY2022 | Dec 31, 2022 | $218.09M | -8.2% |
| Q3 FY2022 | Sep 30, 2022 | $215.40M | -1.6% |
| Q2 FY2022 | Jun 30, 2022 | $216.46M | -3.0% |
| Q1 FY2022 | Mar 31, 2022 | $221.91M | +0.6% |
| Q4 FY2021 | Dec 31, 2021 | $237.50M | +7.3% |
| Q3 FY2021 | Sep 30, 2021 | $218.95M | +2.6% |
| Q2 FY2021 | Jun 30, 2021 | $223.22M | +3.6% |
| Q1 FY2021 | Mar 31, 2021 | $220.58M | +2.4% |
| Q4 FY2020 | Dec 31, 2020 | $221.42M | +33.8% |
| Q3 FY2020 | Sep 30, 2020 | $213.35M | +29.7% |
| Q2 FY2020 | Jun 30, 2020 | $215.49M | +23.4% |
| Q1 FY2020 | Mar 31, 2020 | $215.36M | +22.4% |
| Q4 FY2019 | Dec 31, 2019 | $165.54M | +1.3% |
| Q3 FY2019 | Sep 30, 2019 | $164.44M | +1.7% |
| Q2 FY2019 | Jun 30, 2019 | $174.63M | +15.0% |
| Q1 FY2019 | Mar 31, 2019 | $175.93M | +21.8% |
| Q4 FY2018 | Dec 31, 2018 | $163.46M | +66.4% |
| Q3 FY2018 | Sep 30, 2018 | $161.66M | +66.5% |
| Q2 FY2018 | Jun 30, 2018 | $151.85M | +81.9% |
| Q1 FY2018 | Mar 31, 2018 | $144.42M | +70.0% |
| Q4 FY2017 | Dec 31, 2017 | $98.24M | -5.1% |
| Q3 FY2017 | Sep 30, 2017 | $97.09M | – |
| Q2 FY2017 | Jun 30, 2017 | $83.49M | – |
| Q1 FY2017 | Mar 31, 2017 | $84.94M | – |
| Q4 FY2016 | Dec 31, 2016 | $103.48M | – |
See a number that looks wrong?